Want to see JP:4526 full AI Analyst Report?
4526 Stock Chart & Stats
¥2967.00
-¥30.00(-1.23%)
At close: 4:00 PM EST
¥2967.00
-¥30.00(-1.23%)
Day’s Range― - ―
52-Week Range¥2,662.00 - ¥3,285.00
Previous CloseN/A
Volume73.90K
Average Volume (3M)91.61K
Market Cap
¥71.49B
Enterprise Value¥73.15B
Total Cash (Recent Filing)¥20.07B
Total Debt (Recent Filing)¥7.14B
Price to Earnings (P/E)13.1
Beta0.48
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.63%
Share Statistics
EPS (TTM)238.17
Shares Outstanding30,705,100
10 Day Avg. Volume57,120
30 Day Avg. Volume91,606
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)1.02
Price to Sales (P/S)0.88
P/FCF Ratio91.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)213.9
Revenue Forecast (FY)¥96.20B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthExtremely low leverage and a materially larger equity base give the company durable financial flexibility. That conservatism reduces refinancing and solvency risk, supports continued capex or R&D funding, and allows the business to withstand cyclical pressure without forcing distress sales.
Sustained Revenue GrowthA multi-year pattern of revenue expansion indicates ongoing product acceptance and stable customer relationships. Even with growth normalizing, steady top-line gains underpin scale advantages in manufacturing and provide a platform for margin recovery and incremental investment in new functional products.
Diversified B2B And Consumer ModelSelling both industrial ingredients and packaged consumer products spreads demand risk and enables cross-use of R&D and manufacturing capacity. This vertical mix supports recurring B2B contracts while allowing higher-margin, branded consumer initiatives to capture value from new formulations and trends.
Bears Say
Free Cash Flow DeclineA sharp fall in FCF signals weaker cash conversion and elevated working-capital or reinvestment needs. Persistently lower FCF reduces the company's buffer for organic investment, dividends, or strategic M&A and increases sensitivity to any earnings hiccups or higher capex requirements.
Margin CompressionMaterial margin rollback versus recent peaks suggests pricing pressure, cost increases, or mix shifts away from higher-value products. Lower sustained margins would constrain return on invested capital, limit reinvestment capacity for product development, and make achieving prior profit levels harder.
Earnings Volatility / EPS DeclineA notable negative EPS growth rate reflects earnings normalization after prior recovery and highlights volatility in profitability. Continued EPS weakness hampers internal funding, can pressure investor confidence in management's growth execution, and raises longer-term ROE and payout sustainability questions.
Riken Vitamin Co., Ltd. News
4526 FAQ
What was Riken Vitamin Co., Ltd.’s price range in the past 12 months?
Riken Vitamin Co., Ltd. lowest stock price was ¥2662.00 and its highest was ¥3285.00 in the past 12 months.
What is Riken Vitamin Co., Ltd.’s market cap?
Riken Vitamin Co., Ltd.’s market cap is ¥71.49B.
When is Riken Vitamin Co., Ltd.’s upcoming earnings report date?
Riken Vitamin Co., Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 24 days.
How were Riken Vitamin Co., Ltd.’s earnings last quarter?
Riken Vitamin Co., Ltd. released its earnings results on May 13, 2026. The company reported ¥37.44 earnings per share for the quarter, beating the consensus estimate of N/A by ¥37.44.
Is Riken Vitamin Co., Ltd. overvalued?
According to Wall Street analysts Riken Vitamin Co., Ltd.’s price is currently Overvalued.
Does Riken Vitamin Co., Ltd. pay dividends?
Riken Vitamin Co., Ltd. pays a Semiannually dividend of ¥55 which represents an annual dividend yield of 3.63%. See more information on Riken Vitamin Co., Ltd. dividends here
What is Riken Vitamin Co., Ltd.’s EPS estimate?
Riken Vitamin Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Riken Vitamin Co., Ltd. have?
Riken Vitamin Co., Ltd. has 30,705,100 shares outstanding.
What happened to Riken Vitamin Co., Ltd.’s price movement after its last earnings report?
Riken Vitamin Co., Ltd. reported an EPS of ¥37.44 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.914%.
Which hedge fund is a major shareholder of Riken Vitamin Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4526
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Riken Vitamin Co., Ltd.
Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used in a wide array of products such as baked goods (bread, cake), desserts (whipped topping, ice cream), dairy items (coffee cream, margarine), and other food preparations like tofu, jam, marmalade, cocoa, chocolate, noodles, and mashed potatoes. A specific offering is distilled diglycerine ester, a compound resulting from the interaction of diglycerine with fatty acids. To prolong shelf life, Riken Vitamin supplies natural tocopherol, an antioxidant that prevents oxidation and maintains food freshness. Their product line further encompasses natural food colors and various flavorings suitable for seasoning seafood, poultry, and beef. The company also deals in wakame seaweed, frequently utilized in soups, salads, and instant noodle preparations, alongside integrated stabilizing and emulsifying solutions for frozen treats and dairy products. Additionally, they develop specialized bakery emulsifiers, bread improvers, and cake-enhancing agents. In the chemical realm, Riken Vitamin offers various improving agents, including glycerol, polyglycerol, sorbitan, propylene glycol, and other specialty esters, in addition to vitamins. Established in 1917, the company was initially known as Riken Vitamin Oil Co., Ltd. before rebranding as Riken Vitamin Co., Ltd. in 1980.
Technical Analysis
Ajinomoto Co
―
Morinaga Milk Industry Co., Ltd.
―
Fuji Oil Holdings, Inc.
―
AFC-HD AMS Life Science Co., Ltd.
―
Lacto Japan Co., Ltd.
―
Options Prices
Currently, No data available
---